Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Acq. announced Director departure Appointed director CC transcript
|
X4 Pharmaceuticals, Inc (XFOR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/19/2022 |
SC 13D
| Growth Equity Opportunities 18 VGE, LLC reports a 9.9% stake in * X4 Pharmaceuticals, Inc. |
03/22/2019 |
SC 13D
| Ragan Paula reports a 5% stake in X4 PHARMACEUTICALS, INC. |
12/06/2018 |
SC 13D
| X4 Pharmaceuticals, Inc. reports a 48.2% stake in ARSANIS, INC. |
02/14/2018 |
SC 13D
| SVLSF V, LLC reports a 6.6% stake in ARSANIS, INC. |
11/30/2017 |
SC 13D
| ORBIMED ADVISORS LLC reports a 13.1% stake in ARSANIS, INC. |
11/29/2017 |
SC 13D
| Polaris Venture Partners V, L.P. reports a 13.7% stake in ARSANIS, INC. |
11/29/2017 |
SC 13D
| New Enterprise Associates 16, L.P. reports a 14.6% stake in Arsanis, Inc. |
|
|